References
- SalaffiFDeARStancatiAGrassiWHealth-related quality of life in multiple musculoskeletal conditions: a cross-sectional population based epidemiological study. II. The MAPPING studyClin Exp Rheumatol20052382983916396701
- SalaffiFCarottiMGaspariniSIntorciaMGrassiWThe health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy peopleHealth Qual Life Outcomes200972519296831
- LundkvistJKastangFKobeltGThe burden of rheumatoid arthritis and access to treatment: health burden and costsEur J Health Econ20088Suppl 2S49S6018157732
- JacobssonLTLindrothYMarsalLJuranEBergstromUKobeltGRheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmo, SwedenScand J Rheumatol20073617918317657670
- HallertEHusbergMSkoghTCosts and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project)Rheumatology (Oxford)20064532533116287927
- HuscherDMerkesdalSThieleKZeidlerHSchneiderMZinkACost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in GermanyAnn Rheum Dis2006651175118316540552
- KobeltGSobockiPMuleroJGratacosJPocoviACollantes-EstevezEThe burden of ankylosing spondylitis in SpainValue Health20081140841518489666
- KobeltGWoronoffASRichardBPeetersPSanyJDisease status, costs and quality of life of patients with rheumatoid arthritis in France: the ECO-PR studyJoint Bone Spine20087540841518455949
- MerkesdalSRuofJSchoffskiOBernittKZeidlerHMauWIndirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of diseaseArthritis Rheum20014452853411263766
- PuolakkaKKautiainenHPekurinenMMonetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients’ sickness absence and gross income: experience from the FIN-RACo trialAnn Rheum Dis20066589990416291811
- WolfeFMichaudKChoiHKWilliamsRHousehold income and earnings losses among 6,396 persons with rheumatoid arthritisJ Rheumatol2005321875188316206340
- BrouwerWBKoopmanschapMAHow to calculate indirect costs in economic evaluationsPharmacoeconomics19981356356910180754
- BurtonWMorrisonAMacleanRRudermanESystematic review of studies of productivity loss due to rheumatoid arthritisOccup Med (Lond)200656182716286432
- LiXGignacMAAnisAHThe indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at workMed Care20064430431016565630
- EscorpizoRBombardierCBoonenAWorker productivity outcome measures in arthritisJ Rheumatol2007341372138017552063
- SchultzABChenCYEdingtonDWThe cost and impact of health conditions on presenteeism to employers: a review of the literaturePharmacoeconomics20092736537819586075
- KoopmanschapMBurdorfAJacobKMeerdingWJBrouwerWSeverensHMeasuring productivity changes in economic evaluation: setting the research agendaPharmacoeconomics200523475415693727
- NicholsonSPaulyMVPolskyDShardaCSzrekHBergerMLMeasuring the effects of work loss on productivity with team productionHealth Econ20061511112316200550
- PaulyMVNicholsonSPolskyDBergerMLShardaCValuing reductions in on-the-job illness: ‘presenteeism’ from managerial and economic perspectivesHealth Econ20081746948517628862
- LindeLSorensenJOstergaardMWhat factors influence the health status of patients with rheumatoid arthritis measured by the SF-12v2 Health Survey and the Health Assessment Questionnaire?J Rheumatol2009362183218919723897
- LindeLSorensenJOstergaardMHorslev-PetersenKHetlandMLDoes clinical remission lead to normalization of EQ-5D in patients with RA and is the selection of remission criteria important? A comparative study of 3156 patients and 16136 individuals from the general population [submitted]J Rheumatol20103728529020080905
- ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum1988313153243358796
- HetlandMLLindegaardHMHansenADo changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO RegistryAnn Rheum Dis2008671023102618272669
- van RoijenLEssink-BotMLKoopmanschapMABonselGRuttenFFLabor and health status in economic evaluation of health care. The Health and Labor QuestionnaireInt J Technol Assess Health Care1996124054158840661
- OsterhausJTGuttermanDLPlachetkaJRHealthcare resource and lost labour costs of migraine headache in the USPharmacoeconomics19922677610146980
- BrouwerWBKoopmanschapMARuttenFFProductivity losses without absence: measurement validation and empirical evidenceHealth Policy199948132710539583
- Jacob-TackenKHKoopmanschapMAMeerdingWJSeverensJLCorrecting for compensating mechanisms related to productivity costs in economic evaluations of health care programmesHealth Econ20051443544315497201